Literature DB >> 30806732

ANCA positivity at the time of renal biopsy is associated with chronicity index of lupus nephritis.

Jung Yoon Pyo1, Seung Min Jung2, Jason Jungsik Song2, Yong-Beom Park2,3, Sang-Won Lee4,5.   

Abstract

We investigated the association of antineutrophil cytoplasmic antibody (ANCA) positivity with lupus nephritis (LN) activity, histological features and prognosis in Korean patients with biopsy-proven LN having the results of both myeloperoxidase (MPO-ANCA) and proteinase 3 (PR3)-ANCA. We retrospectively reviewed the medical records of 91 LN patients having the results of ANCA. We divided patients with LN into the two groups according to the ANCA positivity. We collected clinical and laboratory data at kidney biopsy and histological features such as LN class including class I, II, III, IV-S, IV-G and V, and activity and chronicity index. We evaluated prognosis of LN during the follow-up by death and kidney failure. Twelve of 91 patients (13.2%) had ANCA at kidney biopsy. There were no differences in demographic data, comorbidities, reasons for kidney biopsy and laboratory data at kidney biopsy between patients with and without ANCA. In 12 LN patients with ANCA, Class III was the most frequently observed LN class (41.7%), while in 79 LN patients without ANCA, class IV-G was the most often detected LN class (35.4%). There were no meaningful differences in classes of LN between the two groups. On the other hand, patients with ANCA exhibited the higher median chronicity index than those without (2.5 vs. 1.0, P = 0.028), unlike activity index. ANCA positivity exhibited no association with death or kidney failure during the follow-up. ANCA positivity at kidney biopsy is associated with chronicity index of LN.

Entities:  

Keywords:  Antineutrophil cytoplasmic antibody; Histology; Lupus nephritis; Prognosis; Systemic lupus erythematosus

Mesh:

Substances:

Year:  2019        PMID: 30806732     DOI: 10.1007/s00296-019-04263-2

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  23 in total

1.  Renal histology in ANCA-associated vasculitis: differences between diagnostic and serologic subgroups.

Authors:  Herbert A Hauer; Ingeborg M Bajema; Hans C van Houwelingen; Franco Ferrario; Laure-Hélène Noël; Rüdiger Waldherr; David R W Jayne; Niels Rasmussen; Jan A Bruijn; E Christiaan Hagen
Journal:  Kidney Int       Date:  2002-01       Impact factor: 10.612

2.  Natural autoantibodies to myeloperoxidase, proteinase 3, and the glomerular basement membrane are present in normal individuals.

Authors:  Zhao Cui; Ming-hui Zhao; Mårten Segelmark; Thomas Hellmark
Journal:  Kidney Int       Date:  2010-06-30       Impact factor: 10.612

Review 3.  Pathology of lupus nephritis.

Authors:  E J Lewis; M M Schwartz
Journal:  Lupus       Date:  2005       Impact factor: 2.911

4.  The American College of Rheumatology 1990 criteria for the classification of Churg-Strauss syndrome (allergic granulomatosis and angiitis).

Authors:  A T Masi; G G Hunder; J T Lie; B A Michel; D A Bloch; W P Arend; L H Calabrese; S M Edworthy; A S Fauci; R Y Leavitt
Journal:  Arthritis Rheum       Date:  1990-08

5.  Clinical presentation and outcome prediction of clinical, serological, and histopathological classification schemes in ANCA-associated vasculitis with renal involvement.

Authors:  Bertha M Córdova-Sánchez; Juan M Mejía-Vilet; Luis E Morales-Buenrostro; Georgina Loyola-Rodríguez; Norma O Uribe-Uribe; Ricardo Correa-Rotter
Journal:  Clin Rheumatol       Date:  2016-02-06       Impact factor: 2.980

Review 6.  Treatment of severe lupus nephritis: the new horizon.

Authors:  Tak Mao Chan
Journal:  Nat Rev Nephrol       Date:  2014-11-25       Impact factor: 28.314

7.  Class IV-S versus class IV-G lupus nephritis: clinical and morphologic differences suggesting different pathogenesis.

Authors:  Gary S Hill; Michel Delahousse; Dominique Nochy; Jean Bariéty
Journal:  Kidney Int       Date:  2005-11       Impact factor: 10.612

8.  Necrotizing and crescentic lupus nephritis with antineutrophil cytoplasmic antibody seropositivity.

Authors:  Samih H Nasr; Vivette D D'Agati; Hye-Ran Park; Paul L Sterman; Juan D Goyzueta; Robert M Dressler; Shawn M Hazlett; Robert N Pursell; Christopher Caputo; Glen S Markowitz
Journal:  Clin J Am Soc Nephrol       Date:  2008-02-20       Impact factor: 8.237

9.  European consensus statement on the terminology used in the management of lupus glomerulonephritis.

Authors:  C Gordon; D Jayne; C Pusey; D Adu; Z Amoura; M Aringer; J Ballerin; R Cervera; J Calvo-Alén; C Chizzolini; Jm Dayer; A Doria; F Ferrario; J Floege; L Guillevin; M Haubitz; F Hiepe; F Houssiau; P Lesavre; L Lightstone; Pl Meroni; O Meyer; B Moulin; K O'Reilly; M Praga; H Schulze-Koops; Ra Sinico; Kgc Smith; A Tincani; C Vasconcelos; G Hughes
Journal:  Lupus       Date:  2009-03       Impact factor: 2.911

10.  Contribution of renal biopsy data in predicting outcome in lupus nephritis. Analysis of 116 patients.

Authors:  H C Nossent; S C Henzen-Logmans; T M Vroom; J H Berden; T J Swaak
Journal:  Arthritis Rheum       Date:  1990-07
View more
  3 in total

1.  [Clinicopathological features of children with lupus nephritis with positive antineutrophil cytoplasmic antibody].

Authors:  Si-Jia Wen; Li-Zhi Chen; Cheng Cheng; Zhi-Lang Lin; Ying Mo; Xiao-Yun Jiang
Journal:  Zhongguo Dang Dai Er Ke Za Zhi       Date:  2021-01

2.  Level and avidity of antineutrophil cytoplasmic antibodies specific to lactoferrin are useful biomarkers in systemic lupus erythematosus.

Authors:  Mirjana Gajic-Veljic; Branislav Lekic; Milos Nikolic; Jovan Lalosevic; Biljana Stojimirovic; Branka Bonaci-Nikolic
Journal:  Clin Rheumatol       Date:  2021-10-07       Impact factor: 3.650

3.  The Impact of Serum Anti-neutrophil Cytoplasmic Antibody on Clinical Characteristics and Outcomes in Pediatric-Onset Systemic Lupus Erythematosus Patients.

Authors:  Chun-Chun Gau; Min-Hua Tseng; Chao-Yi Wu; Huang-Yu Yang; Jing-Long Huang
Journal:  Front Med (Lausanne)       Date:  2021-04-16
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.